Leadership Overview
BD has 10 executives leading key functions including strategy, information technology, revenue generation, marketing, finance, and operational excellence.
Driven by innovation, BD is dedicated to advancing healthcare solutions and improving patient outcomes globally through cutting-edge medical technologies and comprehensive support for healthcare providers.
Driven by innovation, BD is dedicated to advancing healthcare solutions and improving patient outcomes globally through cutting-edge medical technologies and comprehensive support for healthcare providers.
Leadership Roles at BD
Tom Polen - Chairman, Chief Executive Officer & President
Tom Polen, the Chairman, Chief Executive Officer & President at BD, directs the company's overarching strategy and global operations. Overseeing all business segments, Polen ensures alignment with BD's mission to advance healthcare worldwide. This leadership role involves driving innovation in patient safety, drug delivery, and diagnostics, critical areas for BD's market position. By fostering a culture of continuous improvement, Tom Polen guides the organization toward achieving its financial and operational objectives. The Chairman, Chief Executive Officer & President's strategic vision shapes BD's response to evolving healthcare needs and market dynamics, securing long-term growth and impact across the global healthcare landscape.
Kathryn Wetzel - Chief of Staff & Chief Executive Officer, Office of & Senior VP
Kathryn Wetzel, the Chief of Staff & Chief Executive Officer, Office of & Senior VP at BD, provides strategic support and operational oversight for the executive office. Managing key initiatives and ensuring alignment across departments, Wetzel facilitates the efficient execution of BD's corporate objectives. This role is vital for streamlining operations and enhancing communication between leadership and various business functions. By driving strategic projects and managing the Office of the CEO, Kathryn Wetzel supports BD's mission in medical technology and healthcare solutions. The Chief of Staff & Chief Executive Officer, Office of & Senior VP's organizational skills are critical for BD's effective governance and strategic advancement.
Ravi Dawar - Director, Finance & Chief Financial Officer
Ravi Dawar, the Director, Finance & Chief Financial Officer at BD, oversees the company's financial operations and strategic fiscal planning. Managing all aspects of finance, Dawar ensures robust financial health and drives profitable growth across BD's global operations. This role is paramount for maintaining investor confidence and allocating capital effectively towards innovation in medical technology and healthcare solutions. By implementing rigorous financial controls and forecasting, Ravi Dawar supports BD's mission to improve patient safety and diagnostics. The Director, Finance & Chief Financial Officer's financial acumen is instrumental in guiding BD's long-term strategic and economic objectives.
Glenn McKim - Vice President, Segment Chief Financial Officer
Glenn McKim, the Vice President, Segment Chief Financial Officer at BD, manages the financial performance and strategic planning for specific business segments. Overseeing financial operations within these segments, McKim ensures fiscal discipline and drives profitability for BD's medical technology and healthcare solutions. This role is vital for supporting segment-specific growth initiatives and optimizing resource allocation. By providing critical financial insights, Glenn McKim contributes to informed decision-making across the organization. The Vice President, Segment Chief Financial Officer's financial expertise is key to achieving BD's objectives in areas like patient safety and diagnostics.
Mark Abbasi - Chief Financial Officer, Business Unit Advanced Patient Monitoring Edwards Critical Care)
Mark Abbasi, the Chief Financial Officer, Business Unit Advanced Patient Monitoring Edwards Critical Care) at BD, directs financial strategy and operations for the Advanced Patient Monitoring unit within Edwards Critical Care. Overseeing financial planning, analysis, and reporting, Abbasi ensures the fiscal health and growth of this specialized business. This position is crucial for supporting the development and market introduction of advanced patient monitoring technologies. By managing financial resources effectively, Mark Abbasi contributes to BD's mission of enhancing patient care and safety. The Chief Financial Officer, Business Unit Advanced Patient Monitoring Edwards Critical Care)'s financial leadership is essential for the unit's success and BD's overall market impact.
Ian Sparrow - Chief Information Officer
Ian Sparrow, the Chief Information Officer at BD, architects the company's global technology infrastructure and digital strategy. Overseeing all IT operations, Sparrow ensures robust cybersecurity measures and efficient data management, supporting BD's development of medical devices and diagnostic systems. This role is crucial for integrating advanced technologies across the organization, enhancing operational efficiency and enabling data-driven decision-making. By driving digital transformation initiatives, Ian Sparrow supports BD's commitment to innovation in patient safety and healthcare solutions. The Chief Information Officer's leadership ensures that BD's technological capabilities consistently meet the demands of a rapidly evolving global healthcare market.
Devon Peterson - Director BD Excellence, Chief Revenue Officer
Devon Peterson, the Director BD Excellence, Chief Revenue Officer at BD, spearheads revenue generation strategies and operational excellence initiatives. Overseeing sales and business development functions, Peterson drives market penetration for BD's medical technology and healthcare solutions. This position is vital for maximizing revenue streams and enhancing customer engagement across hospitals and laboratories. By implementing BD Excellence programs, Devon Peterson ensures efficient processes and continuous improvement in service delivery. The Director BD Excellence, Chief Revenue Officer's focus on revenue growth and operational optimization directly contributes to BD's sustained market leadership and financial performance.
Meera Gopalakrishnan - Senior VP & Global Chief Marketing Officer
Meera Gopalakrishnan, the Senior VP & Global Chief Marketing Officer at BD, directs global marketing strategies and brand development. Overseeing all marketing functions, Gopalakrishnan enhances BD's market presence for its medical devices, diagnostic systems, and healthcare solutions. This role is essential for communicating the value of BD's innovations in patient safety and drug delivery to healthcare providers worldwide. By leading integrated marketing campaigns, Meera Gopalakrishnan strengthens customer relationships and drives demand for BD's offerings. The Senior VP & Global Chief Marketing Officer's strategic vision ensures BD remains a recognized leader in the global medical technology sector.
Michael Feld - Chief Revenue Officer & Executive VP, Life Science Segment & Bd Excelllence
Michael Feld, the Chief Revenue Officer & Executive VP, Life Science Segment & Bd Excellence at BD, drives revenue growth and operational efficiency within the Life Science segment. Overseeing key revenue-generating activities and BD Excellence programs, Feld ensures optimal performance and market responsiveness. This leadership position is critical for expanding BD's reach in diagnostics and biosciences, supporting laboratories and healthcare providers. By focusing on strategic revenue expansion and process optimization, Michael Feld directly impacts the segment's profitability and market share. The Chief Revenue Officer & Executive VP, Life Science Segment & Bd Excellence's expertise is vital for BD's continued success in advancing scientific discovery and healthcare.
Denise Fleming - Executive VP, Technology & Global Services & Chief Information Officer
Denise Fleming, the Executive VP, Technology & Global Services & Chief Information Officer at BD, leads the company's technology strategy and global service delivery. Overseeing technology infrastructure and support functions, Fleming ensures seamless operations and drives digital innovation across BD's diverse business units. This dual role is critical for enhancing BD's capabilities in medical devices, diagnostics, and laboratory equipment. By optimizing global services and advancing technological solutions, Denise Fleming supports BD's commitment to healthcare providers worldwide. The Executive VP, Technology & Global Services & Chief Information Officer's leadership ensures BD remains at the forefront of technological advancement in the medical field.
Explore Leadership Teams in Manufacturing
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
CB
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.
Company Leadership
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
WT
DR
DM
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership GE
PL
MR
Frequently Asked Questions Regarding BD Top Executives and Leadership Team
Unlock more people and company data
